Arise is a health care startup based in the United States that aims to revolutionize the approach to eating disorder care. Founded in 2022, the company has already secured a significant $6.48M in a Seed Round investment as of 12 January 2024.
Arise's mission is to address the critical gap in care for those struggling with eating disorders, with a focus on inclusivity and personalized support. They seek to challenge stereotypes and reduce stigma by offering trauma-informed, holistic, and culturally sensitive care, recognizing that eating disorders affect people of all ages, races, sizes, genders, sexual orientations, abilities, and backgrounds. Through their platform, they provide virtual care pathways and ongoing support, aiming to deliver effective care tailored to individual needs.
One of the unique aspects of Arise is its foundation by individuals who have undergone their own healing journeys from eating disorders. This firsthand experience allows the company to empower effective support for others seeking to heal their body and mind.
Arise's innovative approach to tackling a widespread and often overlooked issue in healthcare, along with their strong financial backing, positions them as a promising player in the field of mental health care startups. Their dedication to reshaping the narrative around eating disorders and providing accessible, personalized care demonstrates their potential for long-term impact and success.